152 related articles for article (PubMed ID: 29551026)
1. [Characteristics and prognosis in adult acute myeloid leukemia patients with MLL gene rearrangements].
Gong XY; Wang Y; Liu BC; Wei H; Li CW; Li QH; Zhao JW; Zhou CL; Lin D; Liu KQ; Wei SN; Gong BF; Zhang GJ; Liu YT; Zhao XL; Li Y; Gu RX; Qiu SW; Mi YC; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2018 Jan; 39(1):9-14. PubMed ID: 29551026
[No Abstract] [Full Text] [Related]
2. [Clinical characteristics and prognosis of 34 cases of acute myeloid leukemia with FLT3 internal tandem duplication and MLL gene rearrangement].
Zhou JR; Zhang X; Zhao YL; Yang JF; Zhang JP; Cao XY; Lu Y; Liu DY; Lyu FY; Ouyang J; Lu PH
Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):751-756. PubMed ID: 30369187
[No Abstract] [Full Text] [Related]
3. The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation Over Chemotherapy Alone in the Treatment of Acute Myeloid Leukemia Patients with Mixed Lineage Leukemia (MLL) Rearrangements.
Yang H; Huang S; Zhu CY; Gao L; Zhu HY; Lv N; Jing Y; Yu L
Med Sci Monit; 2016 Jul; 22():2315-23. PubMed ID: 27373985
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and prognosis of
Zhang MX; Shi WZ; Liu JX; Wang CJ; Li Y; Wang W; Jiang B
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):915-920. PubMed ID: 34650294
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic analysis of allogeneic hematopoietic stem-cell transplantation in 47 patients with acute myeloid leukemia and MLL rearrangement].
Jiang SH; Hou C; Chen N; Chen SF; Qiu HY; Xu Y; Chen SN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):558-562. PubMed ID: 30122014
[No Abstract] [Full Text] [Related]
6. Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome.
Kong J; Gao MG; Qin YZ; Wang Y; Yan CH; Sun YQ; Chang YJ; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS
BMC Cancer; 2022 Jan; 22(1):11. PubMed ID: 34979982
[TBL] [Abstract][Full Text] [Related]
7. [Clinical Characteristics and Prognostic Influencing Factors of Adult AML Patients with MLL Rearrangement].
Wang T; Zhao Y; Zhang QQ; Xu LR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):775-780. PubMed ID: 32552935
[TBL] [Abstract][Full Text] [Related]
8. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT
Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia.
Muto T; Takeuchi M; Yamazaki A; Sugita Y; Tsukamoto S; Sakai S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Aotsuka N; Iseki T; Nakaseko C
Int J Hematol; 2015 Jul; 102(1):86-92. PubMed ID: 25758097
[TBL] [Abstract][Full Text] [Related]
10. Monitoring mixed lineage leukemia expression may help identify patients with mixed lineage leukemia--rearranged acute leukemia who are at high risk of relapse after allogeneic hematopoietic stem cell transplantation.
Liu J; Wang Y; Xu LP; Liu DH; Qin YZ; Chang YJ; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2014 Jul; 20(7):929-36. PubMed ID: 24631740
[TBL] [Abstract][Full Text] [Related]
11. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
12. The incidence and distribution characteristics of MLL rearrangements in Chinese acute myeloid leukemia patients by multiplex nested RT-PCR.
Yang H; Cao T; Gao L; Wang L; Zhu C; Xu Y; Jing Y; Zhu H; Lv N; Yu L
Technol Health Care; 2017 Jul; 25(S1):259. PubMed ID: 28582914
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of newly diagnosed acute lymphoblastic leukemia with 11q23/MLL gene rearrangement].
Wang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1092-1096. PubMed ID: 32924108
[TBL] [Abstract][Full Text] [Related]
14. Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia.
Fleischmann M; Schnetzke U; Frietsch JJ; Sayer HG; Schrenk K; Hammersen J; Glaser A; Hilgendorf I; Hochhaus A; Scholl S
J Cancer Res Clin Oncol; 2022 Jun; 148(6):1481-1492. PubMed ID: 34297206
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring
Jiang B; Zhao Y; Luo Y; Yu J; Chen Y; Ye B; Fu H; Lai X; Liu L; Ye Y; Zheng W; Sun J; He J; Zhao Y; Wei G; Cai Z; Huang H; Shi J
Cell Transplant; 2024; 33():9636897231225821. PubMed ID: 38270130
[No Abstract] [Full Text] [Related]
16. Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements.
Issa GC; Zarka J; Sasaki K; Qiao W; Pak D; Ning J; Short NJ; Haddad F; Tang Z; Patel KP; Cuglievan B; Daver N; DiNardo CD; Jabbour E; Kadia T; Borthakur G; Garcia-Manero G; Konopleva M; Andreeff M; Kantarjian HM; Ravandi F
Blood Cancer J; 2021 Sep; 11(9):162. PubMed ID: 34588432
[TBL] [Abstract][Full Text] [Related]
17. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
[TBL] [Abstract][Full Text] [Related]
18. Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML).
Pigneux A; Labopin M; Maertens J; Cordonnier C; Volin L; Socié G; Blaise D; Craddock C; Milpied N; Bacher U; Malard F; Esteve J; Nagler A; Mohty M;
Leukemia; 2015 Dec; 29(12):2375-81. PubMed ID: 26082270
[TBL] [Abstract][Full Text] [Related]
19. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5.
Poirel H; Rack K; Delabesse E; Radford-Weiss I; Troussard X; Debert C; Leboeuf D; Bastard C; Picard F; Veil-Buzyn A; Flandrin G; Bernard O; Macintyre E
Blood; 1996 Mar; 87(6):2496-505. PubMed ID: 8630416
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and molecular biologic characteristics of 36 cases of leukemia with 11q23/mll].
Zhao J; Yin YM; Zhao YL; Sun Y; Wang JB; Zhong J; Zhang X; Fei XH; Shan FX; Liu HX; Wang T; Wang H; Tong CR; Wu T; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1381-5. PubMed ID: 21176334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]